Literature DB >> 1310832

Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus.

D Rohde1, H Hansen, M Hafner, H Lange, V Mielke, M L Hansmann, H Lemke.   

Abstract

The Ki-1 antibody not only detects a Hodgkin-associated membrane molecule of 120 kd (Ki-1/120 = CD30), but also reacts with an independently synthesized molecule of 57 kd (Ki-1/57) that only occurs intracellularly. Hodgkin's disease-derived cell lines L428 and L540 contain both Ki-1-reactive antigens, whereas others, e.g., U266/Bl myeloma cells, only express the intracellular Ki-1/57. The present immunoelectronmicroscopic analysis detected the Ki-1/57 antigen of U266/Bl cells not only in the cytoplasm, but also in association with the nuclear envelope, chromatin structures, and nucleoli. This Ki-1/57-specific type of labeling also was observed in L428 and L540 cells that, in contrast to U266/Bl cells, showed an additional staining of cell membranes and cytoplasmic vesicles. These results were confirmed by two independent methods: 1) cytocentrifuge preparations of isolated nuclei of L540 cells showed a spotted Ki-1-specific labeling, 2) immunoprecipitations demonstrated that the Ki-1/57, but not the Ki-1/120 antigen, was transferred into the nuclei of L540 and U266/Bl cells, whereas the Ki-1/120 antigen with its 90-kd precursor remained in the non-nuclei fraction of L540 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310832      PMCID: PMC1886443     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  The Hodgkin-associated Ki-1 antigen exists in an intracellular and a membrane-bound form.

Authors:  H Hansen; H Lemke; G Bredfeldt; I Könnecke; B Havsteen
Journal:  Biol Chem Hoppe Seyler       Date:  1989-05

2.  Biochemical and structural properties of a Hodgkin's disease-related membrane protein.

Authors:  J F Nawrocki; E S Kirsten; R I Fisher
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

Review 3.  The cell of origin in Hodgkin's disease: conclusions from in vivo and in vitro studies.

Authors:  M Schaadt; H Burrichter; H Stein; M Pfreundschuh; C Fonatsch; V Diehl
Journal:  Int Rev Exp Pathol       Date:  1985

Review 4.  The histogenesis of the Reed-Sternberg cell and its mononuclear counterparts.

Authors:  D B Jones
Journal:  J Pathol       Date:  1987-03       Impact factor: 7.996

5.  Immunoelectron microscopic labeling of immunoglobulin in plasma cells after osmium fixation and epoxy embedding.

Authors:  S A Hearn; M M Silver; J A Sholdice
Journal:  J Histochem Cytochem       Date:  1985-12       Impact factor: 2.479

6.  Evidence of Sternberg-Reed cells being derived from activated lymphocytes.

Authors:  H Stein; J Gerdes; H Lemke; D Y Mason
Journal:  Haematol Blood Transfus       Date:  1985

7.  Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines.

Authors:  P Froese; H Lemke; J Gerdes; B Havsteen; R Schwarting; H Hansen; H Stein
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

8.  Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).

Authors:  R Andreesen; W Brugger; G W Löhr; K J Bross
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

9.  Protein kinase activity of the intracellular but not of the membrane-associated form of the Ki-1 antigen (CD30).

Authors:  H Hansen; G Bredfeldt; B Havsteen; H Lemke
Journal:  Res Immunol       Date:  1990-01

10.  Mycoplasma infection of cell lines can simulate the expression of Fc receptors by binding of the carbohydrate moiety of antibodies.

Authors:  H Lemke; R Krausse; J Lorenzen; B Havsteen
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

View more
  5 in total

1.  Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.

Authors:  Ângela Saito; Edmarcia E Souza; Fernanda C Costa; Gabriela V Meirelles; Kaliandra A Gonçalves; Marcos T Santos; Gustavo C Bressan; Mark E McComb; Catherine E Costello; Stephen A Whelan; Jörg Kobarg
Journal:  J Proteome Res       Date:  2017-07-31       Impact factor: 4.466

2.  CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.

Authors:  U Latza; H D Foss; H Dürkop; F Eitelbach; K P Dieckmann; V Loy; M Unger; G Pizzolo; H Stein
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

3.  High expression of the CD30 molecule in human decidual cells.

Authors:  K Ito; T Watanabe; R Horie; M Shiota; S Kawamura; S Mori
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.

Authors:  L A Noorduyn; P C de Bruin; P van Heerde; M M van de Sandt; G J Ossenkoppele; C J Meijer
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

Review 5.  Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions.

Authors:  Carolina Colleti; Talita Diniz Melo-Hanchuk; Flávia Regina Moraes da Silva; Ângela Saito; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2019-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.